Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Berdikari Pondasi Perkasa Tbk (BDKR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Berdikari Pondasi Perkasa TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Berdikari Pondasi Perkasa Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Berdikari Pondasi Perkasa Tbk trades at Rp163 (market cap 770.19B, 14.46M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Berdikari Pondasi Perkasa Tbk is the larger of the two by market cap, and Berdikari Pondasi Perkasa Tbk is more actively traded (14.46M versus 843K). Which is the better fit depends on your goals.

BDKRLABS
Market Cap
770.19B635.95B
Volume
14.46M843K
Lot
144.63K8.43K
Turnover
2.35B137.6M
Average Price
162.49163.22
Value
2.35B137.6M
Indicative Equilibrium Price
163165
Indicative Equilibrium Volume
605246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BDKR
View details
LABS
View details

About Berdikari Pondasi Perkasa Tbk

PT Berdikari Pondasi Perkasa Tbk (the “Company”) was established on February 27, 1984 based onNotarial Deed No. 81 of Gretha Liestijawatie, S.H. The Company started its commercial operations onFebruary 27, 1984. The controlling interest of the Company is owned by an individual namely Tan John Tanuwijaya.

Read more on BDKR

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS